Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bova UK confirms omeprazole ‘free from testosterone’
“Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

New batch tested following concerns from the racing industry

Drug company Bova UK has confirmed its long-acting injectable omeprazole has been declared free from testosterone, after low levels were found in the product last month.

Supply of the product ceased in Australia after the initial discovery by the New South Wales racing authority.

Samples tested by the British Horseracing Authority (BHA) confirmed the issue extended to the UK and the racing body recently advised against using injectible omeprazole in racehorses.

Testing by the Australian Racing Forensic Laboratory (ARFL) did not detect testosterone in the newly prepared batch of Bova’s 100mg/ml injectable omeprazole formulation.

Racing New South Wales released a statement to confirm that the product can continue to be used in racehorses following the guidance of Australian Commonwealth and State legislation.

Nick Bova, the firm’s managing director, said: “Traces of testosterone in the previous batch were less than one millionth of the internationally accepted standard for impurities. Independent experts confirmed that there could be no adverse effects on equine health or equestrian sport, however, we have taken steps to identify and completely eliminate the excipient ingredient that contained traces of testosterone.

“Bova can confirm that new batches of this product will not contain the previous trace levels of testosterone and therefore Bova are confident there will be no antidoping issues, no matter what the equestrian pursuit is.”

He added: “Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

Following the news, the BHA issued an updated statement on the use of the product: “The BHA are aware of the most recent results from the batch analysed in Australia. Anyone treating thoroughbreds from birth to retirement from racing should consider the latest information, alongside that from analysis of previous batches, in deciding whether to use the product.”

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.